Turkey
Abdi Ibrahim Pharmaceuticals, established in 1912, has firmly positioned itself as a leader in the Turkish pharmaceutical industry. The company's slogan, "İşimiz İyileştirmek" or "Our Business is Healing," encapsulates its longstanding commitment to healthcare excellence. Based in Turkey, Abdi Ibrahim boasts a comprehensive portfolio of approximately 250 brands and over 500 products.
The company actively collaborates with 30 licensors, ensuring a dynamic and expansive product offering. With the distinction of being an industry leader since 2002, Abdi Ibrahim's global reach extends to operations in 19 countries and exports to over 70, including regions from Canada to the European Union, North Africa, and Asia.
Notably, Abdi Ibrahim employs nearly 5,800 individuals, marking it as a major employment provider within Turkey's pharmaceutical sector. Its innovative edge is bolstered by state-of-the-art facilities, including AbdiBio, Türkiye's largest biotechnological manufacturing unit, and extensive R&D centers in Kazakhstan and Algeria.
Abdi Ibrahim's commitment to sustainability is evidenced by its adherence to United Nations Global Principles since 2010, and its active engagement with the Global Reporting Initiative (GRI), where it maintains an A-level focus on sustainability reporting.
